| Abbreviations | Full |
| AST | antimicrobial susceptibility testing |
| CA | community-acquired; CAMERA |
| CAMERA | combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection (clinical trial) |
| CAP | community-acquired pneumonia |
| CC | clonal complex |
| CDC | US Centers for Disease Control and Prevention |
| cgMLST | core genome multi-locus sequence typing |
| CLSI | Clinical and Laboratory Standards Institute |
| CoNS | coagulase-negative Staphylococcus |
| CO-MRSA | community-onset MRSA |
| CRISPR/Cas9 | lustered regularly interspaced short palindromic repeats/CRISPR associated protein 9 |
| CYP | cytochrome P450 |
| DHFR | dihydrofolate-reductase |
| ESBL | extended-spectrum β-lactamase |
| ESCMID | European Society of Clinical Microbiology and Infectious Diseases |
| EU | European Union |
| EUCAST | European Committee on Antimicrobial Susceptibility Testing |
| FDA | US Food and Drug Administration |
| HA | hospital-associated |
| HAP | hospital-acquired pneumonia |
| hVISA | heterogeneous vancomycin-intermediate S. aureus |
| HLA | human leukocyte antigen |
| IAI | intra-abdominal infection |
| LA | livestock-associated |
| MALDI-TOF MS | matrix-assisted laser desorption/ionization time-of-flight mass spectrometry |
| MAO-A | monoamine-oxidase-A |
| MFS | major facilitator superfamily |
| MDR | multidrug-resistant |
| MIC | minimal inhibitory concentration |
| MLST | multi-locus sequence typing |
| MRSA | methicillin/oxacillin-resistant S. aureus |
| NGS | next-generation sequencing |
| NP | nanoparticle |
| OPAT | outpatient parenteral antibiotic therapy |
| PFGE | pulse-field gel electrophoresis |
| PBP | penicillin-binding protein |
| QS | quorum sensing |
| UTI | urinary tract infection |
| PDI | prosthetic device infection |
| PCR | polymerase chain reaction |
| PVL | Panton–Valentine leucocidin |
| QRDR | quinolone resistance-determining region |
| QTc | corrected QT-interval |
| RNA | ribonucleic acid |
| RNAi | RNA-interference |
| SCV | small-colony variant |
| SMX/TMP | co-trimoxazole |
| SSTI | skin and soft tissue infection |
| ST | sequence type |
| ssDNA | single-strand DNA |
| ssRNA | single-strand RNA |
| TDM | therapeutic drug monitoring |
| TAT | turnaround time |
| TLR | toll-like receptor |
| TSS | toxic shock syndrome |
| TSST | toxic shock syndrome toxin |
| UTI | urinary tract infection |
| VAP | ventilator-associated pneumonia |
| VISA | vancomycin-intermediate S. aureus |
| VNTR | variable number tandem repeat |
| VRE | vancomycin-resistant enterococci |
| VRSA | vancomycin-resistant S. aureus |
| WGS | whole-genome sequencing |